Kleinman, K S <br/><br/>
The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial.  [electronic resource] 

 -  American journal of kidney diseases : the official journal of the National Kidney Foundation  Dec 1989 
 - 486-95 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0272-6386 
<br/><br/><label>Standard No.: </label>10.1016/s0272-6386(89)80149-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anemia--drug therapy<br/>Double-Blind Method<br/>Erythropoietin--therapeutic use<br/>Female<br/>Hematocrit<br/>Humans<br/>Kidney Failure, Chronic--complications<br/>Kidney Function Tests<br/>Male<br/>Middle Aged<br/>Potassium--blood<br/>Quality of Life<br/>Randomized Controlled Trials as Topic<br/>Recombinant Proteins--therapeutic use<br/>Renal Dialysis<br/>Time Factors